Monthly Archives: October 2009

Pharma Celebrates its Own

By Andrew Sheivachman | Published: October 7, 2009
At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage. “The most successful new [cancer] therapies will be based on a precise molecular understanding of disease basis—that’s exactly what we did with Gleevec,” said keynote speaker Brian Druker, director of the Oregon Health [...]
Posted in Events | Tagged , , , , , , , , , , , , , | Leave a comment

Prix Galien Push for Private/Public Collaboration

By Andrew Sheivachman | Published: October 6, 2009
Preceding the presentation of the 2009 Prix Galien USA prizes, last Tuesday, a round table discussion was conducted at the American Museum of Natural History on the subject of how public and private collaboration can increase innovation and contribute to saving lives around the world. The talk included Leonard Bell of Alexion Pharmaceuticals, Barry Bloom [...]
Posted in Events | Tagged , , , , , , , , | Leave a comment

On-Demand Webcast: Develop Competitive Advantage Through Business Analytics in the New Pharma Commercial Model

By George Koroneos | Published: October 6, 2009
Originally Recorded on September 14, 2009 As we all know, the industry is facing trends that will continue to erode profitability if the sales and marketing model does not change. The image of a new commercial model is now starting to emerge – and although the details are far from clear, the basic components are there [...]
Posted in Webcast | Tagged , , , , , , , , | Leave a comment